4//SEC Filing
Clark David J 4
Accession 0000899243-18-006818
CIK 0001341235other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:40 PM ET
Size
7.6 KB
Accession
0000899243-18-006818
Insider Transaction Report
Form 4
Clark David J
Chief Medical Officer
Transactions
- Award
Common Stock
2017-12-29$4.00/sh+4,774$19,072→ 4,774 total - Award
Employee Stock Option (Right to Buy)
2018-03-06+108,633→ 108,633 totalExercise: $8.60Exp: 2028-03-05→ Common Stock (108,633 underlying)
Footnotes (3)
- [F1]Represents the voluntary reporting of 4,774 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in December 2017.
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on July 3, 2017.
- [F3]The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2018.
Documents
Issuer
Aldeyra Therapeutics, Inc.
CIK 0001341235
Entity typeother
Related Parties
1- filerCIK 0001662693
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 4:40 PM ET
- Size
- 7.6 KB